Sanofi threatens suit after Canada clears generic Lovenox

03/15/2005 | Reuters

Sanofi-Aventis has threatened to sue Novopharm for patent infringement in the wake of Canadian regulatory approval for Novopharm to market its generic version of Lovenox in the country. A Sanofi spokesman said the company was "taken by surprise" by the Ministry of Health's action, and would seek a preliminary injunction barring Teva Pharmaceutical's subsidiary from marketing its generic.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC